We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Botulinum Relieves Chronic Back Pain

By HospiMedica staff writers
Posted on 22 Oct 2000
Botulinum A, the same deadly toxin associated with botulism food poisoning, has demonstrated the ability to bring relief to patients suffering from chronic lower back pain. More...
Injected into a localized area in extremely low concentrations, the toxin blunts the nerve endings responsible for muscle spasms.

In a study of 19 patients, in which nine received two injections of botulinum toxin into both sides of the lower back and 10 received no treatment, researchers found that the botulinum group had significant reductions in pain, improvements in ability to function, and fewer muscle spasms. The nontreatment group reported an increase in pain and no improvement in muscle spasms. The botulinum injections begin working in two to three days, but their effects can last for months, say the researchers.

"Unlike acute back pain, which tends to resolve on its own, chronic back pain tends to worsen over time due to a vicious, self-perpetuating cycle of muscle spasms,” said Randall C. Cork, M.D., professor and chair of anesthesiology at Louisiana State University Health Sciences Center (Shreveport, USA), where the research was conducted. One drawback is the medication's tendency to become less and less effective with repeated injections as the body builds up antibodies to the toxin. "But most patients never need another injection,” said Dr. Cork.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.